The largest database of trusted experimental protocols

5 protocols using pe conjugated anti cd133

1

Multiparameter Flow Cytometry for Cell Subpopulation Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dissociated cells were resuspended at 1×106 cells/ml in DMEM + 2% FBS prior to the addition of MIC1-1C3 hybridoma supernatant (at a 1:20 dilution) or a 1:200 dilution of purified MIC1-1C3 antibody (Novus) and incubation at 4°C (for 30’). After a wash with cold DPBS, cells were resuspended in DMEM + 2% FBS containing a 1:200 dilution of APC-conjugated goat anti-rat secondary antibody adsorbed against mouse serum proteins (Jackson Immunoresearch). After another wash, cells were resuspended in DMEM + 5% rat serum (Serotec) and held on ice (10’) to block the secondary antibody. A final incubation with FITC-conjugated anti-CD26 (BD Biosciences, Franklin Lakes, NJ), PE-conjugated anti-CD133 (eBioscience, San Diego, CA) and PE-Cy7-conjugated anti-CD45 (BD Biosciences) + anti-CD11b/Mac1 (BD Biosciences) + anti-CD31 (Abcam, Cambridge, MA) facilitated cell subfractionation and exclusion gating of hematopoietic (CD45+, CD11b+) and endothelial (CD31+) cells. Propidium iodide staining was used to label dead cells for exclusion. Cells were analyzed and sorted with a Cytopeia inFluxV-GS (Becton-Dickenson, Franklin Lakes, NJ); FSC : Pulse-width gating was used to exclude cell doublets from analysis and collection.
+ Open protocol
+ Expand
2

Isolation and Culture of Endothelial Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were collected and cultured as aforementioned. Cell aliquots (1×106) were incubated for 20 min at 4°C with the following anti-mouse antibodies: APC-conjugated anti-CD11b (dilution, 1:100; BioLegend, Inc.), FITC-conjugated anti-CD31 (cat. no. 102506; dilution, 1:50; BioLegend, Inc.), Per CP-conjugated anti-CD144 (cat. no. 46-1441-82; dilution, 1:50; eBioscience; Thermo Fisher Scientific, Inc.) and PE-conjugated anti-CD133 (cat. no. 141203; dilution, 1:40; BioLegend, Inc.). Acquisition was performed using a FACSAria flow cytometer, and data were analyzed using FACSDiva software version 6.1.3. Sorted CD133+/CD31+/CD144+/CD11b cells were enriched by further culture in endothelial growth basal medium (EBM)-2 (Lonza Group, Ltd., Basel, Switzerland).
+ Open protocol
+ Expand
3

Multicolor Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
FITC-conjugated anti-CD44, PerCP-conjugated anti-CD3, PE-conjugated anti-CD8, FITC-conjugated anti-Granzyme A, anti-Granzyme B, anti-perforin and anti-IFN-γ were all purchased from BD Pharmingen. PE-conjugated anti-CD133 was purchased from eBiosciences. For cell surface staining, SMMC7721 and HepG2 cells were resuspended in 100μl staining buffer containing 10% FBS and put on ice for 20 min to block Fc receptors, then incubated with FITC-conjugated anti-CD44and PE-conjugated anti-CD133or isotype control for 30 min. The cells were then washed with 1ml ice-cold staining buffer for 2 times and centrifuged (300g) at 4°C for 5 min. The collected cells were suspended in 500μl staining buffer solution. PBMCs were incubated with SMMC7721 cells for 5 hours with brefeldin A at a final concentration of 10μg/ml, then collected and washed. As discussed above, PerCP-conjugated anti-CD3 and PE-conjugated anti-CD8 were used for surface staining. After that, cells were fixed and permeabilized, and then intracellular staining of FITC-conjugated anti-GranzymeA, Granzyme B, perforin and IFN-γ was performed. All samples after staining were evaluated using BD FACS Canto II with Diva software and analyzed using Flowjo 7.6.5.
+ Open protocol
+ Expand
4

Lung Tissue Cell Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Suspended BM non-red blood cells and single-cell suspensions freshly obtained from collagenasedigested lung tissues were labeled with FITCconjugated anti-CD34 (560238, BD Biosciences, USA), PE-conjugated anti-CD133 (12-1331, eBioscience, USA), and APC-conjugated anti-Flk-1 (560070, BD Biosciences, USA) at 4oC for 30 min in the dark. Approximately, 5×105 (link) cells were analyzed by flow cytometry for each experiment using a FACSCaliburTM flow cytometer (BD Biosciences, USA).
+ Open protocol
+ Expand
5

Isolation and Characterization of Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adherent cells were detached with 0.05% Trypsin (Corning, Manassas, VA), washed and re-suspended in phosphate buffered saline (PBS). Tumors were mechanically and enzymatically disaggregated into single-cell suspensions, as in [35 (link)]. 1×106 cells were incubated with PE-conjugated anti-CD133 and/or FITC-conjugated anti-CD44 (eBioscience, San Diego, CA; 12-1338-42 and 11-0441-82). Labeled cells were analyzed by LSR Fortessa Cell Analyzer (BD Bioscience). Data was analyzed with Flowjo software. At least three samples were analyzed in triplicate and a normal distribution was observed for biological replicates.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!